The Market for RFID Tags and Systems in Healthcare and Pharmaceuticals Will Rise From $85.24 Million in 2007 to $2.05 Billion in 2017
Research and Markets (http://www.researchandmarkets.com/reports/c89905) has announced the addition of RFID for Healthcare and Pharmaceuticals 2008-2018 to their offering.
This unique report gives a full technical and market analysis
The RFID business is growing so fast that few applicational sectors can beat that scorching rate of growth. Healthcare and pharmaceuticals is one of them thanks to the new tagging of drugs, real time location of staff and patients and other developments including automated error prevention. This unique report gives a full technical and market analysis illustrated by 70 case studies. It is a vital resource for the healthcare profession and all who wish to support it.
Rapid increase in adoption
The market for RFID tags and systems in healthcare and pharmaceuticals will rise rapidly from $85.24 million in 2007 to $2.05 billion in 2017. Primarily, this will be because of item level tagging of drugs and Real Time Locating Systems (RTLS) for staff, patients and assets to improve efficiency, safety and availability and to reduce losses.
Companies Mentioned:
Pfizer Viagra USA
GlaxoSmithKline
Abbott Laboratories
Cephalon, tracking pharmaceuticals, France, Germany, UK, USA
CVS Pharmacy USA
Felletti Spadazzi Italy
GS1 Europe
HD Smith USA
Johnson & Johnson USA
McKesson USA
Millennium Pharmaceutical UK
Novartis USA
Purdue Pharma USA
Ranbaxy Pharmaceuticals India
UK Pharmaceutical UK
Unimed Pharma Korea
Walgreens USA
West Pharmaceutical Services USA
Cardinal Health USA
Felletti Spadazzi, drug cases, Italy
Bang & Olufsen Medicaid, Denmark
Precision Dynamics, USA
Brenmoor UK
Fischer Clinical Services drug trials item level, USA
Melexis, Belgium
AstraZeneca, UK
Baptist Health USA
Veterans V/A Hospitals USA
Regenesis Biomedical USA
Mediplus, UK
South Tyneside Healthcare Trust UK
Electrolux, Germany
Uchida Yoko, Japan
Yoshikawa, Japan
Hitachi, Japan
For more information visit http://www.researchandmarkets.com/reports/c89905